Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LIFT XL
London, London, United Kingdomliftxl.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
LIfT BioSciences has developed a first-in-class allogeneic neutrophil-based cell therapy platform. Their lead product uses Immunomodulatory Alpha Neutrophils (IMANs) derived from hematopoietic stem cells to directly kill tumor cells and modulate the immune system. Preclinical data show potent anti-tumor activity and reprogramming of the tumor microenvironment. The company is preparing for its first Phase 1 trial in solid tumors such as pancreatic, lung, and gastric cancers.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyAllogeneic cell therapyImmunomodulatory Alpha Neutrophils (IMANs)CAR-modified cell therapy (future pipeline)
- Industry
- Biotech
02
Partnerships
University of Galway – clinical trial collaboration in IrelandBayer Co.Lab Cambridge – lab facilities partnershipPharmaceutical industry partners for advancing CAR-iN-LIfT therapies
Beyond the preview
Go deeper on LIFT XL.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LIFT XL.